Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease

NCT00138840 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
282
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Synta Pharmaceuticals Corp.